Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$232.35 -5.93 (-2.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018)

Updated

Jazz Pharmaceuticals (JAZZ) reported Restructuring Costs of $44 million for Q2 2018.

Analysis

Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018) Analysis & Trends

Over the twelve months ended Jun 30, 2018, Jazz Pharmaceuticals' Restructuring Costs came in at $57.7 million.

  • The Q2 2018 figure ranks as the highest quarterly Restructuring Costs in data going back to Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Jazz Pharmaceuticals 15.47 Bn 9.29 Bn 1.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 44.00 Mn
Sep 30, 2016 10.80 Mn
Jun 30, 2016 2.20 Mn
Sep 30, 2014 700,000.00
Jun 30, 2014 4.40 Mn
Mar 31, 2014 17.10 Mn
Jun 30, 2013 400,000.00
Jun 30, 2012 8.90 Mn
Mar 31, 2012 3.50 Mn
Sep 30, 2011 6.00 Mn
API Access

Jazz Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=JAZZ&period=max&api_key=YOUR_API_KEY